This impact was prevented by co-administration of the CB1 receptor antagonist SR141716a, although not by co-administration with the CB2 receptor antagonist SR144528, suggesting this action of WIN55,212-2 is mediated by way of (2014) Effects of cannabinoid medicines over the deficit of prepulse inhibition of startle within an animal model of https://win55.clinic/xo-so